Concept registers across the pond to offer pharma testing for US market
UK-headquartered Concept Life Sciences says completing FDA registration means it can test raw pharmaceutical materials and finished products for the US market.
UK-headquartered Concept Life Sciences says completing FDA registration means it can test raw pharmaceutical materials and finished products for the US market.
CRO executives are being urged to write letters of support for more high throughput clinical research centres in the UK, which could help attract foreign investment, says IAOCR.
The US FDA has drawn industry attention to the potential of 3D printing and continuous manufacturing, which it says could “improve drug quality, address shortages of medicines, lower drug costs, and bring pharmaceutical manufacturing back to the US”.
The UK has voted in favour of continuing its involvement in the EMA’s regulatory network, once it withdraws from the European Union.
AstraZeneca says it will stockpile a further 20% of its medicines into its UK inventory that it holds to export to the European Union.